Chemeq raises $10m
Wednesday, 09 June, 2004
Perth pharmaceutical company Chemeq (ASX:CMQ) has raised AUD$10 million from a share placement to institutional and private clients with Bell Potter Securities.
Chemeq will use the fund from the placement, whch was made at $4.55 a share, to improve the productivity and efficiency of its new Perth manufacturing plan. The company is in the final stages of commissioning the plant for commercial production of its novel veterinary anti-microbial for the pig and poultry industries.
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
Archer completes potassium sensing alpha prototype
Quantum technology company Archer Materials Limited has developed an early Biochip prototype...
Farm animals and aquaculture cryopreservation partnership announced
Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...
